Skip to content

Faculty Member

Kevin A. Brown

Email Address(es)
Office Phone
Office Address
480 University Avenue, Suite 300 Toronto, ON M5G 1V2
Epidemiology Division
Associate Professor
SGS Status
Associate Member
Appointment Status
Status Only

Academic degrees and accreditations

  • Doctor of Philosophy (Epidemiology), Dalla Lana School of Public Health, University of Toronto
  • Master of Science (Biostatistics), University of North Carolina at Chapel Hill

Research interests

  • Validating medico-administrative and electronic medical record data
  • Identifying facility factors that drive hospital-acquired infection rates
  • Describing patient movement between healthcare facilities and the community
  • Statistical methods for measuring risk factor magnitude and duration

Selected publications

  • Slayton RB, Toth D, Lee BY, Tanner W, Bartsch SM, Khader K, Wong K, Brown K, McKinnell JA, Ray W, Miller LG, Rubin M, Kim DS, Adler F, Cao C, Avery L, Stone NTB, Kallen A, Samore M, Huang SS, Fridkin S, Jernigan JA. Vital Signs: Estimated Effects of a Coordinated Approach for Action to Reduce Antibiotic-Resistant Infections in Health Care Facilities – United States. MMWR Morb Mortal Wkly Rep 2015; 64:826–831. Link
  • Jones BE, Jones MM, Huttner B, Stoddard G, Brown KA, Stevens VW, Greene T, Sauer B, Madaras-Kelly K, Rubin M, Goetz MB, Samore M. Trends in Antibiotic Use and Nosocomial Pathogens in Hospitalized Veterans with Pneumonia at 128 Medical Centers, 2006–2010. Clinical Infectious Diseases 2015; 61:1403–1410. Link
  • Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital Ward Antibiotic Prescribing and the Risks of Clostridium difficile Infection. JAMA Intern Med. 2015;175(4):626–633. Link
  • Brown KA, Arora P, Daneman N, Moineddin R, and Fisman D. The Co–Seasonality of Pneumonia and Influenza with Clostridium difficile Infection (CDI) in the United States, 1993 to 2008. Am J of Epi 2013; 178:118–125. Link
  • Brown KA, Khanafer N, Daneman N, Fisman DN. Meta–Analysis of Antibiotics and the Risk of Community–Associated Clostridium difficile Infection. Antimicrob Agents Chemother 2013; 57:2326–2332. Link
  • Lambert L, Brown KA, Segal E, Brophy J, Rodes–Cabau J, Bogaty P. Association between timeliness of reperfusion therapy and clinical outcomes in ST–elevation myocardial infarction. JAMA 2010; 303:2148. Link